Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Quebec's Multi-Party Observatory on Zoonoses and Adaptation to Climate Change.

Germain G, Simon A, Arsenault J, Baron G, Bouchard C, Chaumont D, El Allaki F, Kimpton A, Lévesque B, Massé A, Mercier M, Ogden NH, Picard I, Ravel A, Rocheleau JP, Soto J; for Quebec’s Multi-Party Observatory on Zoonoses and Adaptation to Climate Change.

Can Commun Dis Rep. 2019 May 2;45(5):143-148. doi: 10.14745/ccdr.v45i05a05. eCollection 2019 May 2.

2.

Atorvastatin restricts the ability of influenza virus to generate lipid droplets and severely suppresses the replication of the virus.

Episcopio D, Aminov S, Benjamin S, Germain G, Datan E, Landazuri J, Lockshin RA, Zakeri Z.

FASEB J. 2019 Aug;33(8):9516-9525. doi: 10.1096/fj.201900428RR. Epub 2019 May 24.

PMID:
31125254
3.

Healthcare costs of stroke and major bleeding in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants.

Rozjabek HM, Coleman CI, Ashton V, Laliberté F, Oyefesobi P, Lejeune D, Germain G, Schein JR, Yuan Z, Lefebvre P, Peterson ED.

J Med Econ. 2019 Aug;22(8):751-759. doi: 10.1080/13696998.2019.1603156. Epub 2019 Apr 25.

PMID:
30939954
4.

Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population.

Bogart M, Stanford RH, Laliberté F, Germain G, Wu JW, Duh MS.

Int J Chron Obstruct Pulmon Dis. 2019 Feb 19;14:343-352. doi: 10.2147/COPD.S184653. eCollection 2019.

5.

Kinetic Analyses of the Siderophore Biosynthesis Inhibitor Salicyl-AMS and Analogues as MbtA Inhibitors and Antimycobacterial Agents.

Bythrow GV, Mohandas P, Guney T, Standke LC, Germain GA, Lu X, Ji C, Levendosky K, Chavadi SS, Tan DS, Quadri LEN.

Biochemistry. 2019 Feb 12;58(6):833-847. doi: 10.1021/acs.biochem.8b01153. Epub 2019 Jan 10.

PMID:
30582694
6.

Ejection fraction, B-type natriuretic peptide and risk of stroke and acute myocardial infarction among patients with heart failure.

Greenberg B, Peterson ED, Berger JS, Laliberté F, Zhao Q, Germain G, Lejeune D, Wu JW, Lefebvre P, Fonarow GC.

Clin Cardiol. 2019 Feb;42(2):277-284. doi: 10.1002/clc.23140. Epub 2019 Jan 7.

7.

Modeling the impact of real-world adherence to once-daily (QD) versus twice-daily (BID) non-vitamin K antagonist oral anticoagulants on stroke and major bleeding events among non-valvular atrial fibrillation patients.

McHorney CA, Peterson ED, Ashton V, Laliberté F, Crivera C, Germain G, Sheikh N, Schein J, Lefebvre P.

Curr Med Res Opin. 2019 Apr;35(4):653-660. doi: 10.1080/03007995.2018.1530205. Epub 2018 Oct 30.

PMID:
30265159
8.

Health characteristics of patients with asthma, COPD and asthma-COPD overlap in the NHANES database.

Llanos JP, Ortega H, Germain G, Duh MS, Lafeuille MH, Tiggelaar S, Bell CF, Hahn B.

Int J Chron Obstruct Pulmon Dis. 2018 Sep 12;13:2859-2868. doi: 10.2147/COPD.S167379. eCollection 2018.

9.

Burden of disease associated with a COPD eosinophilic phenotype.

Ortega H, Llanos JP, Lafeuille MH, Germain G, Duh MS, Bell CF, Sama SR, Hahn B.

Int J Chron Obstruct Pulmon Dis. 2018 Aug 13;13:2425-2433. doi: 10.2147/COPD.S170995. eCollection 2018.

10.

Effects of systemic corticosteroids on blood eosinophil counts in asthma: real-world data.

Ortega H, Llanos JP, Lafeuille MH, Duh MS, Germain G, Lejeune D, Sama S, Bell C, Hahn B.

J Asthma. 2019 Aug;56(8):808-815. doi: 10.1080/02770903.2018.1502301. Epub 2018 Oct 16.

PMID:
30130418
11.

Inflammasome-derived cytokine IL18 suppresses amyloid-induced seizures in Alzheimer-prone mice.

Tzeng TC, Hasegawa Y, Iguchi R, Cheung A, Caffrey DR, Thatcher EJ, Mao W, Germain G, Tamburro ND, Okabe S, Heneka MT, Latz E, Futai K, Golenbock DT.

Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):9002-9007. doi: 10.1073/pnas.1801802115. Epub 2018 Aug 20.

12.

Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users.

McHorney CA, Crivera C, Laliberté F, Germain G, Wynant W, Lefebvre P.

PLoS One. 2018 Apr 5;13(4):e0194099. doi: 10.1371/journal.pone.0194099. eCollection 2018.

13.

Risk of Ischemic Stroke in Patients Newly Diagnosed With Heart Failure: Focus on Patients Without Atrial Fibrillation.

Berger JS, Peterson E, LalibertÉ F, Germain G, Lejeune D, Schein J, Lefebvre P, Zhao Q, Weir MR.

J Card Fail. 2019 Jun;25(6):436-447. doi: 10.1016/j.cardfail.2018.03.012. Epub 2018 Mar 27.

14.

Adherence to Rivaroxaban Compared with Other Oral Anticoagulant Agents Among Patients with Nonvalvular Atrial Fibrillation.

McHorney CA, Ashton V, Laliberté F, Germain G, Wynant W, Crivera C, Schein JR, Lefebvre P, Peterson ED.

J Manag Care Spec Pharm. 2017 Sep;23(9):980-988. doi: 10.18553/jmcp.2017.23.9.980.

15.

Health care resource utilization before and after perampanel initiation among patients with epilepsy in the United States.

Faught E, Laliberté F, Wang Z, Barghout V, Haider B, Lejeune D, Germain G, Choi J, Wagh A, Duh MS.

Epilepsia. 2017 Oct;58(10):1742-1748. doi: 10.1111/epi.13857. Epub 2017 Jul 25.

16.

Dynamic Covalent Chemistry of Carbon Dioxide: Opportunities to Address Environmental Issues.

Septavaux J, Germain G, Leclaire J.

Acc Chem Res. 2017 Jul 18;50(7):1692-1701. doi: 10.1021/acs.accounts.7b00147. Epub 2017 Jun 23.

PMID:
28644617
17.

Mycobacteria Encode Active and Inactive Classes of TesB Fatty-Acyl CoA Thioesterases Revealed through Structural and Functional Analysis.

Swarbrick CM, Bythrow GV, Aragao D, Germain GA, Quadri LE, Forwood JK.

Biochemistry. 2017 Mar 14;56(10):1460-1472. doi: 10.1021/acs.biochem.6b01049. Epub 2017 Mar 2.

PMID:
28156101
18.

Treatment persistence and hospitalization rates among patients with schizophrenia: a quasi-experiment to evaluate a patient information program.

Pilon D, Amos TB, Germain G, Lafeuille MH, Lefebvre P, Benson CJ.

Curr Med Res Opin. 2017 Apr;33(4):713-721. doi: 10.1080/03007995.2016.1277989. Epub 2017 Feb 13.

PMID:
28055336
19.

Stroke risk reduction outweighed bleeding risk increase from vitamin K antagonist treatment among nonvalvular atrial fibrillation patients with high stroke risk and low bleeding risk.

Nelson WW, Laliberté F, Patel AA, Germain G, Pilon D, McCormick N, Lefebvre P.

Curr Med Res Opin. 2017 Apr;33(4):631-638. doi: 10.1080/03007995.2016.1275936. Epub 2017 Jan 24.

PMID:
28008771
20.

Comparison of Adherence to Rivaroxaban Versus Apixaban Among Patients With Atrial Fibrillation.

McHorney CA, Peterson ED, Laliberté F, Germain G, Nelson WW, Crivera C, Schein J, Lefebvre P.

Clin Ther. 2016 Nov;38(11):2477-2488. doi: 10.1016/j.clinthera.2016.09.014. Epub 2016 Oct 24.

PMID:
27789043
21.

Hospitalizations and Other Health Care Resource Utilization Among Patients with Deep Vein Thrombosis Treated with Rivaroxaban Versus Low-molecular-weight Heparin and Warfarin in the Outpatient Setting.

Deitelzweig S, Laliberté F, Crivera C, Germain G, Bookhart BK, Olson WH, Schein J, Lefebvre P.

Clin Ther. 2016 Aug;38(8):1803-1816.e3. doi: 10.1016/j.clinthera.2016.07.002. Epub 2016 Aug 2.

PMID:
27491278
22.

Control of the innate immune response by the mevalonate pathway.

Akula MK, Shi M, Jiang Z, Foster CE, Miao D, Li AS, Zhang X, Gavin RM, Forde SD, Germain G, Carpenter S, Rosadini CV, Gritsman K, Chae JJ, Hampton R, Silverman N, Gravallese EM, Kagan JC, Fitzgerald KA, Kastner DL, Golenbock DT, Bergo MO, Wang D.

Nat Immunol. 2016 Aug;17(8):922-9. doi: 10.1038/ni.3487. Epub 2016 Jun 6.

23.

Dengue-induced autophagy, virus replication and protection from cell death require ER stress (PERK) pathway activation.

Datan E, Roy SG, Germain G, Zali N, McLean JE, Golshan G, Harbajan S, Lockshin RA, Zakeri Z.

Cell Death Dis. 2016 Mar 3;7:e2127. doi: 10.1038/cddis.2015.409.

24.

Cerebral Oximetry Monitoring to Maintain Normal Cerebral Oxygen Saturation during High-risk Cardiac Surgery: A Randomized Controlled Feasibility Trial.

Deschamps A, Hall R, Grocott H, Mazer CD, Choi PT, Turgeon AF, de Medicis E, Bussières JS, Hudson C, Syed S, Seal D, Herd S, Lambert J, Denault A, Deschamps A, Mutch A, Turgeon A, Denault A, Todd A, Jerath A, Fayad A, Finnegan B, Kent B, Kennedy B, Cuthbertson BH, Kavanagh B, Warriner B, MacAdams C, Lehmann C, Fudorow C, Hudson C, McCartney C, McIsaac D, Dubois D, Campbell D, Mazer D, Neilpovitz D, Rosen D, Cheng D, Drapeau D, Dillane D, Tran D, Mckeen D, Wijeysundera D, Jacobsohn E, Couture E, de Medicis E, Alam F, Abdallah F, Ralley FE, Chung F, Lellouche F, Dobson G, Germain G, Djaiani G, Gilron I, Hare G, Bryson G, Clarke H, McDonald H, Roman-Smith H, Grocott H, Yang H, Douketis J, Paul J, Beaubien J, Bussières J, Pridham J, Armstrong JN, Parlow J, Murkin J, Gamble J, Duttchen K, Karkouti K, Turner K, Baghirzada L, Szabo L, Lalu M, Wasowicz M, Bautista M, Jacka M, Murphy M, Schmidt M, Verret M, Perrault MA, Beaudet N, Buckley N, Choi P, MacDougall P, Jones P, Drolet P, Beaulieu P, Taneja R, Martin R, Hall R, George R, Chun R, McMullen S, Beattie S, Sampson S, Choi S, Kowalski S, McCluskey S, Syed S, Boet S, Ramsay T, Saha T, Mutter T, Chowdhury T, Uppal V, Mckay W; Canadian Perioperative Anesthesia Clinical Trials Group.

Anesthesiology. 2016 Apr;124(4):826-36. doi: 10.1097/ALN.0000000000001029.

PMID:
26808629
25.

Predictors of high healthcare resource utilization and liver disease progression among patients with chronic hepatitis C.

LaMori J, Tandon N, Laliberté F, Germain G, Pilon D, Lefebvre P, Prabhakar A.

J Med Econ. 2016;19(4):364-73. doi: 10.3111/13696998.2015.1127252. Epub 2016 Jan 11.

PMID:
26624985
26.

Perioperative management of patients with obstructive sleep apnea: a survey of Canadian anesthesiologists.

Cordovani L, Chung F, Germain G, Turner K, Turgeon AF, Hall R, Gay PC, Bryson GL, Choi PT; Canadian Perioperative Anesthesia Clinical Trials Group.

Can J Anaesth. 2016 Jan;63(1):16-23. doi: 10.1007/s12630-015-0512-y. Epub 2015 Oct 19.

PMID:
26481938
27.

Economic outcomes with prasugrel versus clopidogrel in acute coronary syndrome patients: observations from prasugrel users and matched clopidogrel users.

Olson WH, Ma YW, Crivera C, Schein J, Lefebvre P, Laliberté F, Dea K, Germain G, Lynch SM.

J Med Econ. 2015;18(12):1074-84. doi: 10.3111/13696998.2015.1076429. Epub 2015 Sep 25.

28.

Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure.

McHorney CA, Crivera C, Laliberté F, Nelson WW, Germain G, Bookhart B, Martin S, Schein J, Lefebvre P, Deitelzweig S.

Curr Med Res Opin. 2015 Dec;31(12):2167-73. doi: 10.1185/03007995.2015.1096242. Epub 2015 Oct 22.

PMID:
26393483
29.

Costs of hospital visits among patients with deep vein thrombosis treated with rivaroxaban and LMWH/warfarin.

Merli GJ, Hollander JE, Lefebvre P, Laliberté F, Raut MK, Germain G, Bookhart B, Pollack CV.

J Med Econ. 2016;19(1):84-90. doi: 10.3111/13696998.2015.1096274. Epub 2015 Oct 27.

PMID:
26390315
30.

Pharmacy quality alliance measure: adherence to non-warfarin oral anticoagulant medications.

Crivera C, Nelson WW, Bookhart B, Martin S, Germain G, Laliberté F, Schein J, Lefebvre P.

Curr Med Res Opin. 2015;31(10):1889-95. doi: 10.1185/03007995.2015.1077213. Epub 2015 Sep 4.

PMID:
26211815
31.

Daily costs of hospitalization in non-valvular atrial fibrillation patients treated with anticoagulant therapy.

Dasta JF, Pilon D, Mody SH, Lopatto J, Laliberté F, Germain G, Bookhart BK, Lefebvre P, Nutescu EA.

J Med Econ. 2015;18(12):1041-9. doi: 10.3111/13696998.2015.1074583. Epub 2015 Aug 26.

PMID:
26201251
32.

Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users.

Laliberté F, Cloutier M, Crivera C, Nelson WW, Olson WH, Schein J, Vanderpoel J, Germain G, Lefebvre P.

Adv Ther. 2015 Apr;32(4):387. doi: 10.1007/s12325-015-0202-8. No abstract available.

33.

Effect of rivaroxaban versus warfarin on health care costs among nonvalvular atrial fibrillation patients: observations from rivaroxaban users and matched warfarin users.

Laliberté F, Cloutier M, Crivera C, Nelson WW, Olson WH, Schein J, Vanderpoel J, Germain G, Lefebvre P.

Adv Ther. 2015 Mar;32(3):216-27. doi: 10.1007/s12325-015-0189-1. Epub 2015 Mar 18. Erratum in: Adv Ther. 2015 Apr;32(4):387.

34.

Effects of rivaroxaban versus warfarin on hospitalization days and other health care resource utilization in patients with nonvalvular atrial fibrillation: an observational study from a cohort of matched users.

Laliberté F, Cloutier M, Crivera C, Nelson WW, Olson WH, Schein J, Vanderpoel J, Germain G, Lefebvre P.

Clin Ther. 2015 Mar 1;37(3):554-62. doi: 10.1016/j.clinthera.2015.02.001. Epub 2015 Mar 4. Erratum in: Clin Ther. 2015 Aug;37(8):1870-1.

35.

Reply: Essential need for research in hepatitis C.

Tandon N, Balart LA, Laliberté F, Pilon D, Lefebvre P, Germain G, Prabhakar A.

J Med Econ. 2015;18(7):514-5. doi: 10.3111/13696998.2015.1017504. Epub 2015 Apr 24. No abstract available.

PMID:
25744591
36.

Daily hospitalization costs in patients with deep vein thrombosis or pulmonary embolism treated with anticoagulant therapy.

Dasta JF, Pilon D, Mody SH, Lopatto J, Laliberté F, Germain G, Bookhart BK, Lefebvre P, Nutescu EA.

Thromb Res. 2015 Feb;135(2):303-10. doi: 10.1016/j.thromres.2014.11.024. Epub 2014 Dec 4.

37.

Hospital length of stay of nonvalvular atrial fibrillation patients who were administered Rivaroxaban versus Warfarin with and without pretreatment parenteral anticoagulants therapies.

Laliberté F, Pilon D, Raut MK, Nelson WW, Olson WH, Germain G, Schein JR, Lefebvre P.

Hosp Pract (1995). 2014 Aug;42(3):17-25. doi: 10.3810/hp.2014.08.1114.

PMID:
25255403
38.

Prasugrel vs. clopidogrel in acute coronary syndrome patients treated with prasugrel.

Olson WH, Ma YW, Laliberté F, Lefebvre P, Crivera C, Schein JR, Fields LE, Dea K, Germain G, Lynch SM.

J Clin Pharm Ther. 2014 Dec;39(6):663-72. doi: 10.1111/jcpt.12209. Epub 2014 Sep 23.

PMID:
25252190
39.

In-plane ultrasound-guided needle insertion ALONG or ACROSS the visual axis hand positions.

Wilson JM, Germain G, Vaghadia H, Tang R, Sawka A.

Br J Anaesth. 2014 Oct;113(4):717-8. doi: 10.1093/bja/aeu324. No abstract available.

40.

Impact of completing chronic hepatitis C (CHC) treatment on post-therapy healthcare cost.

Tandon N, Balart LA, Laliberté F, Pilon D, Lefebvre P, Germain G, Prabhakar A.

J Med Econ. 2014 Dec;17(12):862-71. doi: 10.3111/13696998.2014.964720. Epub 2014 Oct 8.

PMID:
25215925
41.

Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation?

Laliberté F, Pilon D, Raut MK, Nelson WW, Olson WH, Germain G, Schein JR, Lefebvre P.

Curr Med Res Opin. 2014 Aug;30(8):1521-8. doi: 10.1185/03007995.2014.916159. Epub 2014 May 2.

PMID:
24758611
42.

Hospital length of stay: is rivaroxaban associated with shorter inpatient stay compared to warfarin among patients with non-valvular atrial fibrillation?

Laliberté F, Pilon D, Raut MK, Nelson WW, Olson WH, Germain G, Schein JR, Lefebvre P.

Curr Med Res Opin. 2014 Apr;30(4):645-53. doi: 10.1185/03007995.2013.867843. Epub 2013 Dec 5.

PMID:
24256067
43.

A multiscale model of the electrohysterogram the BioModUE_PTL project.

Marque C, Laforêt J, Rabotti C, Alexandersson A, Germain G, Gondry J, Karlsson B, Leskosek B, Mischi M, Muszinski C, Oei G, Peuscher J, Rudel D.

Conf Proc IEEE Eng Med Biol Soc. 2013;2013:7448-51. doi: 10.1109/EMBC.2013.6611280.

PMID:
24111467
44.

Reversal of early abnormalities in glucose metabolism in obese youth: results of an intensive lifestyle randomized controlled trial.

Savoye M, Caprio S, Dziura J, Camp A, Germain G, Summers C, Li F, Shaw M, Nowicka P, Kursawe R, Depourcq F, Kim G, Tamborlane WV.

Diabetes Care. 2014 Feb;37(2):317-24. doi: 10.2337/dc13-1571. Epub 2013 Sep 23.

45.

Bivariate piecewise stationary segmentation; improved pre-treatment for synchronization measures used on non-stationary biological signals.

Terrien J, Germain G, Marque C, Karlsson B.

Med Eng Phys. 2013 Aug;35(8):1188-96. doi: 10.1016/j.medengphy.2012.12.010. Epub 2013 Jan 26.

PMID:
23357338
46.

Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment.

Doridot L, Passet B, Méhats C, Rigourd V, Barbaux S, Ducat A, Mondon F, Vilotte M, Castille J, Breuiller-Fouché M, Daniel N, le Provost F, Bauchet AL, Baudrie V, Hertig A, Buffat C, Simeoni U, Germain G, Vilotte JL, Vaiman D.

Hypertension. 2013 Mar;61(3):662-8. doi: 10.1161/HYPERTENSIONAHA.111.202994. Epub 2013 Jan 28.

PMID:
23357179
47.

Evaluation of the durability of composite tidal turbine blades.

Davies P, Germain G, Gaurier B, Boisseau A, Perreux D.

Philos Trans A Math Phys Eng Sci. 2013 Jan 14;371(1985):20120187. doi: 10.1098/rsta.2012.0187. Print 2013 Feb 28.

PMID:
23319705
48.

Epidural analgesia in parturients with ankylosing spondylitis: a role for ultrasound surveillance and ultrasound-guided placement.

Vaghadia H, Germain G, Tang R.

Can J Anaesth. 2013 Feb;60(2):206. doi: 10.1007/s12630-012-9822-5. Epub 2012 Nov 22. No abstract available.

PMID:
23180059
49.

Pre- and post-partum mild underfeeding influences gene expression in the reproductive tract of cyclic dairy cows.

Valour D, Hue I, Degrelle SA, Déjean S, Marot G, Dubois O, Germain G, Humblot P, Ponter AA, Charpigny G, Grimard B.

Reprod Domest Anim. 2013 Jun;48(3):484-99. doi: 10.1111/rda.12113. Epub 2012 Nov 7.

PMID:
23131127
50.

Brief reports: a comparison of an injection cephalad or caudad to the division of the sciatic nerve for ultrasound-guided popliteal block: a prospective randomized study.

Germain G, Lévesque S, Dion N, Nadeau MJ, Coté D, Nicole PC, Turgeon AF.

Anesth Analg. 2012 Jan;114(1):233-5. doi: 10.1213/ANE.0b013e3182373887. Epub 2011 Oct 14.

PMID:
22003214

Supplemental Content

Loading ...
Support Center